Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Ovarian Cancer 2011 NCI 5R01CA077429-12 Basis for Lymphomagenesis in Akt2 Transgenic Mice TESTA, JOSEPH FOX CHASE CANCER CENTER PA $419,987
Ovarian Cancer 2011 NCI 5R01CA131407-04 Re-activating Memory T Cells in the Microenvironment of Human Tumors BANKERT, RICHARD STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $335,421
Ovarian Cancer 2011 NCI 5R01CA104996-07 Promoting Tumor Immunity by Cross-linking B7-DC PEASE, LARRY MAYO CLINIC MN $239,311
Ovarian Cancer 2011 NCI 5R01CA119200-05 Optical Imaging of Ovarian Carcinogenesis in a Rat Menopause Model BARTON, JENNIFER UNIVERSITY OF ARIZONA AZ $274,008
Ovarian Cancer 2011 NCI 5R01CA103937-07 Molecular Diagnostics for Malignant Effusion SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $328,003
Ovarian Cancer 2011 NCI 5R01CA123233-04 Regulation of JNK-signaling molecules by the gep oncogenes DHANASEKARAN, DANNY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $1
Ovarian Cancer 2011 NCI 5R01CA124630-05 PTTG Role in Ovarian Tumorigenesis and Matastasis KAKAR, SHAM UNIVERSITY OF LOUISVILLE KY $245,488
Ovarian Cancer 2011 NCI 5R01CA142838-02 Role of redox state in ovarian cancer response to cisplatin DANIEL, LARRY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $292,962
Ovarian Cancer 2011 NCI 5R01CA047135-22 Discovery of novel cytotoxic natural products from marine sponges and fungi CREWS, PHIL UNIVERSITY OF CALIFORNIA SANTA CRUZ CA $462,978
Ovarian Cancer 2011 NCI 5R01CA144057-07 Evaluation of Vectors based on group B adenoviruses LIEBER, ANDRE UNIVERSITY OF WASHINGTON WA $320,779
Ovarian Cancer 2011 NCI 5R01CA114340-05 Antiangiogenic Gene Therapy of Ovarian and Breast Cancers RAMAKRISHNAN, SUNDARAM UNIVERSITY OF MINNESOTA TWIN CITIES MN $245,614
Ovarian Cancer 2011 NCI 5R01CA124951-02 Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy FANG, BINGLIANG UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $309,964
Ovarian Cancer 2011 NCI 5R01CA129080-04 The Roles of HBXAP Gene in Ovarian Cancer SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $330,091
Ovarian Cancer 2011 NCI 5R21CA143736-02 Development of a multimarker urine-based test for early diagnosis and screening o LOKSHIN, ANNA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $191,776
Ovarian Cancer 2011 NCI 5R01CA142776-02 The role of microRNA, mir-30d, in the initiation and progression of cancer ZHANG, LIN UNIVERSITY OF PENNSYLVANIA PA $322,040
Ovarian Cancer 2011 NCI 5R01CA095175-08 Analysis of BRCA1 recombination functions SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER MA $295,223
Ovarian Cancer 2011 NCI 5R01CA123249-04 Regulation of Serine Protease HtrA1 and Chemoresponse SHRIDHAR, VIJI MAYO CLINIC MN $304,127
Ovarian Cancer 2011 NCI 5R01CA102707-07 Inhibition of Cytochrome c-induced Caspase Activation KORNBLUTH, SALLY DUKE UNIVERSITY NC $263,055
Ovarian Cancer 2011 NCI 5R01CA133057-03 Prognostic markers for ovarian cancer MOK, SAMUEL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $287,595
Ovarian Cancer 2011 NCI 5R01CA132091-04 Targeted Nanoparticle DNA Therapy for Ovarian Cancer SAWICKI, JANET LANKENAU INSTITUTE FOR MEDICAL RESEARCH PA $266,946
Ovarian Cancer 2011 NCI 5R01CA123197-05 Death Receptor-mediated Apoptosis and Therapy Strategies in Ovarian Cancer ZHOU, TONG UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $444,659
Ovarian Cancer 2011 NIEHS 5R01ES005775-19 Hypoxia, Genetic Instability and DNA Mismatch Repair GLAZER, PETER YALE UNIVERSITY CT $364,578
Ovarian Cancer 2011 NCI 5R01CA101850-07 ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING BAE, YOU UNIVERSITY OF UTAH UT $263,045
Ovarian Cancer 2011 NCI 5R01CA109298-07 Ovarian Cancer: Mechanisms of Neuroendocrine Regulation SOOD, ANIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $338,690
Ovarian Cancer 2011 NIGMS 5R01GM052418-12 Mass Spectrometry Studies on Radical Reactions of DNA KENTTAMAA, HILKKA PURDUE UNIVERSITY WEST LAFAYETTE IN $210,739
Ovarian Cancer 2011 NCI 5R01CA133117-03 Role of the Mullerian Tract in Ovarian Cancer Development DUBEAU, LOUIS UNIVERSITY OF SOUTHERN CALIFORNIA CA $326,066
Ovarian Cancer 2011 NCI 1R01CA155025-01 The role of a novel BRCA1 associated complex in DNA damage response and tumor sup WANG, BIN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $327,850
Ovarian Cancer 2011 NCI 5R01CA114343-05 Haplotype-Based Genome Screen for Ovarian Cancer Loci SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $1,078,602
Ovarian Cancer 2011 NCI 5R01CA141078-02 Multifunctional roles of homeobox gene DLX4 in ovarian cancer NAORA, HONAMI UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $318,015
Ovarian Cancer 2011 NCI 5R01CA108970-07 CD4+ Memory T-Cells in Human Tumor Microenvironment BANKERT, RICHARD STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $296,719
Ovarian Cancer 2011 NIDCR 1R03DE021438-01 Genetic Markers Associated with Epithelial Ovarian Cancer and Hypodontia MORFORD, LORRI UNIVERSITY OF KENTUCKY KY $111,375
Ovarian Cancer 2011 NCI 1R21CA155424-01 Enzyme-delivery scaffold technology for targeted cancer killing. LAVIE, ARNON UNIVERSITY OF ILLINOIS AT CHICAGO IL $231,069
Ovarian Cancer 2011 NCI 5R01CA120659-04 Role of a novel angiogenic factor, YKL-40, in breast cancer progression SHAO, RONG UNIVERSITY OF MASSACHUSETTS AMHERST MA $218,062
Ovarian Cancer 2011 NCI 1R21CA155479-01 Use of nanogels to target delivery of siRNA to cancer cells in mice MCDONALD, JOHN GEORGIA INSTITUTE OF TECHNOLOGY GA $240,470
Ovarian Cancer 2011 NCI 5R01CA149356-11 The Role of MicroRNAs in Tumor Progression PETER, MARCUS NORTHWESTERN UNIVERSITY AT CHICAGO IL $283,051
Ovarian Cancer 2011 NCI 5R03CA139905-02 Sociocultural Factors and BRCA Genetic Counseling for Diverse Latinas SUSSNER, KATARINA MOUNT SINAI SCHOOL OF MEDICINE NY $82,208
Ovarian Cancer 2011 NCI 5R01CA116167-05 BRCA2 missense mutations and breast cancer COUCH, FERGUS MAYO CLINIC MN $512,304
Ovarian Cancer 2011 NCI 5R03CA150039-02 MITOCHONDRIAL GENOME ANALYSIS OF EPITHELIAL SEROUS OVARIAN CARCINOMA AIKHIONBARE, FELIX MOREHOUSE SCHOOL OF MEDICINE GA $70,000
Ovarian Cancer 2011 NCI 5R21CA137681-02 A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers CHILES, THOMAS BOSTON COLLEGE MA $211,697
Ovarian Cancer 2011 NCI 5R01CA131200-03 Regulation of Ovarian Cancer Multidrug Resistance by MAP Kinases EBLEN, SCOTT MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $296,116
Ovarian Cancer 2011 NIGMS 5SC1GM082340-02 The Fulvene Approach to the Syntheses of Antitumor Agents ERDEN, IHSAN SAN FRANCISCO STATE UNIVERSITY CA $265,939
Ovarian Cancer 2011 NCI 5R01CA123219-04 The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology MILLS, GORDON UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $305,140
Ovarian Cancer 2011 NCI 7R01CA136549-03 Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas LU, XIONGBIN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $318,015
Ovarian Cancer 2011 NCI 5R03CA150136-02 Validating Cancer Risk Models: a Pilot Study to Evaluate Cost-efficient Methods WHITTEMORE, ALICE STANFORD UNIVERSITY CA $80,078
Ovarian Cancer 2011 NCI 2R01CA079716-12A1 Ovarian Cancer: Epithelial Dedifferentiation XU, XIANGXI MIKE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $326,412
Ovarian Cancer 2011 NICHD 5R01HD057110-04 Molecular Pathways Controlling Ovarian Gene Expression STOCCO, CARLOS UNIVERSITY OF ILLINOIS AT CHICAGO IL $288,726
Ovarian Cancer 2011 NCI 7R01CA140323-02 Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer GODWIN, ANDREW UNIVERSITY OF KANSAS MEDICAL CENTER KS $366,458
Ovarian Cancer 2011 NCI 1R03CA143918-01A1 Characteristics of tubal ligation and risk of epithelial ovarian cancer TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $101,020
Ovarian Cancer 2011 NCI 5R01CA134424-03 A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc KOSTUK, RAYMOND UNIVERSITY OF ARIZONA AZ $429,845
Ovarian Cancer 2011 NCI 5R21CA150237-02 Targeting lipid metabolic and signaling enzyme in ovarian cancer NG, SHU-WING BRIGHAM AND WOMEN'S HOSPITAL MA $230,673
Ovarian Cancer 2011 NCI 5R01CA142832-02 Novel Biomarkers in Ovarian Cancer BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $347,562
Ovarian Cancer 2011 NCI 5R01CA149429-02 The Mitochondrial Genome and Ovarian Cancer Risk PHELAN, CATHERINE H. LEE MOFFITT CANCER CTR & RES INST FL $624,525
Ovarian Cancer 2011 NCI 5R01CA099985-05 Human Tregs in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $216,969
Ovarian Cancer 2011 NCI 5R01CA139159-03 Signal Transduction Enzyme Inhibitors from Extremophilic Microbes as Anticancer A STIERLE, ANDREA UNIVERSITY OF MONTANA MT $209,710
Ovarian Cancer 2011 NCI 5R01CA136596-03 The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis CONNOLLY, DENISE FOX CHASE CANCER CENTER PA $316,103
Ovarian Cancer 2011 NCI 5R01CA138762-03 Splicing factors as therapeutic targets for the treatment of ovarian cancer BECK, WILLIAM UNIVERSITY OF ILLINOIS AT CHICAGO IL $303,952
Ovarian Cancer 2011 NCI 5R01CA131183-04 RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression LIU, JINSONG UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $247,971
Ovarian Cancer 2011 NCI 5R01CA116984-06 G Proteins and Their Receptors in Tumor Cell Metastasis DHANASEKARAN, DANNY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $289,351
Ovarian Cancer 2011 NCI 5R01CA123088-05 Novel immunosupressive macrophages in human ovarian tumor ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $280,136
Ovarian Cancer 2011 NCI 5R01CA136494-03 Molecular mechanism of antiangiogenic properties of gold nanoparticle MUKHERJEE, PRIYABRATA MAYO CLINIC MN $273,714
Ovarian Cancer 2011 NCI 5R01CA136547-03 Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer PENG, KAH-WHYE MAYO CLINIC MN $424,154
Ovarian Cancer 2011 NCI 1R21CA156944-01 Biophotonics Noninvasive Detection of Ovarian Cancer BACKMAN, VADIM NORTHWESTERN UNIVERSITY IL $329,563
Ovarian Cancer 2011 NCI 1R01CA157176-01 Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer BICKELL, NINA MOUNT SINAI SCHOOL OF MEDICINE NY $528,302
Ovarian Cancer 2011 NCI 5R01CA136491-03 Development of an Assay for the Early Detection of Ovarian Cancer MOORE, RICHARD WOMEN AND INFANTS HOSPITAL-RHODE ISLAND RI $414,995
Ovarian Cancer 2011 NCI 5R01CA135006-03 Role of TbRIII in Regulating Motility and Invasion BLOBE, GERARD DUKE UNIVERSITY NC $425,769
Ovarian Cancer 2011 NCI 5R01CA137041-03 MicroRNAs in Human Ovarian Cancer CHENG, JIN H. LEE MOFFITT CANCER CTR & RES INST FL $336,129
Ovarian Cancer 2011 NCI 5R01CA086984-12 Regulation of Ovarian Carcinoma Proteinases STACK, MARY UNIVERSITY OF MISSOURI-COLUMBIA MO $292,490
Ovarian Cancer 2011 NCI 5K08CA148887-02 Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer KHABELE, DINEO VANDERBILT UNIVERSITY TN $159,084
Ovarian Cancer 2011 NCI 5R01CA138556-03 Impact of exercise on ovarian cancer prognosis IRWIN, MELINDA YALE UNIVERSITY CT $631,739
Ovarian Cancer 2011 NCI 5R01CA039742-27 Epidemiology of Cancer in a Cohort of Older Women ROBIEN, KIMBERLY UNIVERSITY OF MINNESOTA TWIN CITIES MN $444,188
Ovarian Cancer 2011 NCI 5R01CA122728-04 Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE SANTIN, ALESSANDRO YALE UNIVERSITY CT $329,744
Ovarian Cancer 2011 NCI 5R01CA131965-03 Defining a Pre-Malignant Phenotype in Fallopian Tube Epithelium SWISHER, ELIZABETH UNIVERSITY OF WASHINGTON WA $313,989
Ovarian Cancer 2011 NCI 5R01CA127913-04 MyD88-bearing tumors in immune-regulation and chemo-resistance MOR, GIL YALE UNIVERSITY CT $333,111
Ovarian Cancer 2011 NCI 5R01CA124515-06 Vascular Leukocytes influence the tumor microenvironment CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $312,204
Ovarian Cancer 2011 NCI 5R01CA121187-06 Monitoring of advanced virotherapy for ovarian cancer CURIEL, DAVID WASHINGTON UNIVERSITY MO $280,136
Ovarian Cancer 2011 NCI 1R33CA147988-01A1 Development and Application of Novel Glycan-Specific Reagents to Facilitate Early MUDDIMAN, DAVID NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $330,496
Ovarian Cancer 2011 NCI 5R01CA132755-04 MOLECULAR MECHANISMS OF BRCA1-DEPENDENT DNA DAMAGE RESPONSE AND TUMORIGENESIS YU, XIAOCHUN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $305,938
Ovarian Cancer 2011 NCI 5R01CA094172-10 Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas CHO, KATHLEEN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $253,343
Ovarian Cancer 2011 NCI 5R01CA135179-03 INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS SCHWARTZ, MARC GEORGETOWN UNIVERSITY DC $382,346
Ovarian Cancer 2011 NCI 5R01CA114037-05 Taxane Resistance in Breast and Ovarian Cancer Cells SIKIC, BRANIMIR STANFORD UNIVERSITY CA $288,798
Ovarian Cancer 2011 NCI 5R01CA130911-04 Chimeric NKG2D receptors in ovarian cancer immunotherapy SENTMAN, CHARLES DARTMOUTH COLLEGE NH $321,839
Ovarian Cancer 2011 NCI 5R01CA126841-03 Regulatory T Cell Function in Ovarian Cancer MOYSICH, KIRSTEN ROSWELL PARK CANCER INSTITUTE CORP NY $626,563
Ovarian Cancer 2011 OD 5R01CA126841-03 Regulatory T Cell Function in Ovarian Cancer MOYSICH, KIRSTEN ROSWELL PARK CANCER INSTITUTE CORP NY $15,000
Ovarian Cancer 2011 NCI 5K07CA143047-02 Genetic Epidemiology of Ovarian and Prostate Cancer SIEH, WEIVA STANFORD UNIVERSITY CA $173,448
Ovarian Cancer 2011 NCI 5R01CA125636-05 The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer TANIGUCHI, TOSHIYASU FRED HUTCHINSON CANCER RESEARCH CENTER WA $310,947
Ovarian Cancer 2011 NCI 5R01CA135312-04 Dendritic nanomedicine for cancer imaging and treatment TUNG, CHING-HSUAN METHODIST HOSPITAL RESEARCH INSTITUTE TX $301,913
Ovarian Cancer 2011 NCI 5R01CA142081-02 Epidemiology of Ovarian Cancer in African-American Women SCHILDKRAUT, JOELLEN DUKE UNIVERSITY NC $2,239,114
Ovarian Cancer 2011 NCI 5R21CA137686-03 High-throughput intracellular microrheology: a new tool for cancer research WIRTZ, DENIS JOHNS HOPKINS UNIVERSITY MD $201,131
Ovarian Cancer 2011 NCI 5R01CA136512-03 BRCA1 Function in Post-Damage Nuclear Foci LIVINGSTON, DAVID DANA-FARBER CANCER INSTITUTE MA $511,671
Ovarian Cancer 2011 NCI 5R01CA124545-04 TRAIL Receptor Signaling in Human Tumors THORBURN, ANDREW UNIVERSITY OF COLORADO DENVER CO $412,266
Ovarian Cancer 2011 NCI 5R01CA058598-13 Collaborative Genetic Study of Ovarian Cancer Risk GOODMAN, MARC UNIVERSITY OF HAWAII AT MANOA HI $482,794
Ovarian Cancer 2011 NCI 5R01CA140933-03 Biobehavioral Influences and the Ovarian Tumor Microenvironment LUTGENDORF, SUSAN UNIVERSITY OF IOWA IA $534,427
Ovarian Cancer 2011 NCI 5R01CA115780-06 Diagnosis of Ovarian Cancer by Confocal Microendoscopy GMITRO, ARTHUR UNIVERSITY OF ARIZONA AZ $277,038
Ovarian Cancer 2011 NCI 5R01CA131400-03 VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER SPRINGETT, GREGORY H. LEE MOFFITT CANCER CTR & RES INST FL $336,129
Ovarian Cancer 2011 NCI 5R01CA099471-07 Gonadotropins & Cox-2 in Ovarian Cancer Prevention XU, XIANGXI MIKE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $375,772
Ovarian Cancer 2011 NCI 5R01CA120429-05 Regulation of MDR1 Expression and Drug Resistance by CD44 RODRIGUEZ-RODRIGUEZ, LORNA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $287,508
Ovarian Cancer 2011 NCI 1R01CA157664-01 Initiation and evolution of the ovarian cancer microenvironment CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $363,981
Ovarian Cancer 2011 NCI 5R01CA031841-31 Synthetic Studies on Tumor Promoters and Inhibitors WENDER, PAUL STANFORD UNIVERSITY CA $329,840
Ovarian Cancer 2011 NIGMS 1R01GM097495-01 Cross-talk between PKA, cellular tension, and Ca2+ channels during cell migration HOWE, ALAN UNIVERSITY OF VERMONT & ST AGRIC COLLEGE VT $282,913
Ovarian Cancer 2011 NIGMS 5R01GM088055-12 Structural and Functional Characterization of BRCA1/BARD1 KLEVIT, RACHEL UNIVERSITY OF WASHINGTON WA $370,628
Ovarian Cancer 2011 NCI 5R01CA142783-02 Signaling in the ovarian cancer metastatic microenvironment SLACK-DAVIS, JILL UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $309,964
Ovarian Cancer 2011 NCI 1R01CA158881-01 Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer COLEMAN, TIMOTHY NEMUCORE MEDICAL INNOVATIONS, INC. MA $568,797
Ovarian Cancer 2011 NINR 5R01NR010735-04 Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-Directed DONOVAN, HEIDI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $555,577
Ovarian Cancer 2011 NCI 5R01CA138628-02 Role of the BMP SMADs in Oncogenesis PANGAS, STEPHANIE BAYLOR COLLEGE OF MEDICINE TX $354,370
Ovarian Cancer 2011 NCI 5R01CA115483-07 Therapeutic Targeting Agents for Ovarian Cancer LAM, KIT UNIVERSITY OF CALIFORNIA DAVIS CA $299,038
Ovarian Cancer 2011 NCI 5U10CA027469-31 Gynecologic Oncology Group DISAIA, PHILIP GYNECOLOGIC ONCOLOGY GROUP MD $9,434,066
Ovarian Cancer 2011 NCI 5R01CA148747-02 Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer CLIBY, WILLIAM MAYO CLINIC MN $317,411
Ovarian Cancer 2011 NCI 5R21CA137684-02 Novel targeted therapies for BRCA-associated cancer WEITZEL, JEFFREY CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $334,117
Ovarian Cancer 2011 NCI 5R01CA138533-02 Multifunctional Nanotherapeutics for Cancer Treatment and Imaging MINKO, TAMARA RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK NJ $307,721
Ovarian Cancer 2011 NCI 5R33CA110499-05 Molecular Profiling to Predict Response to Chemotherapy LANCASTER, JOHNATHAN H. LEE MOFFITT CANCER CTR & RES INST FL $266,563
Ovarian Cancer 2011 NCI 2R15CA125731-02A1 Functional Outcomes of Cdk6 and Eya2 Interaction GROSSEL, MARTHA CONNECTICUT COLLEGE CT $419,375
Ovarian Cancer 2011 RMAP 1R21NS074091-01 High-throughput imaging of Hedgehog pathway components at the primary cilium ROHATGI, RAJAT STANFORD UNIVERSITY CA $158,000
Ovarian Cancer 2011 NCI 5U01CA128535-05 Early Cancer Detection & Prognosis through Glycomics NOVOTNY, MILOS INDIANA UNIVERSITY BLOOMINGTON IN $361,949
Ovarian Cancer 2011 NCI 5R37CA070867-14 Cancer Risk Reduction and Diet: A Cohort Study of Women ZHENG, WEI VANDERBILT UNIVERSITY TN $945,286
Ovarian Cancer 2011 NCI 1R01CA148826-01A1 Characterizing Notch3 Signaling in Ovarian Cancer WANG, TIAN-LI JOHNS HOPKINS UNIVERSITY MD $340,300
Ovarian Cancer 2011 NCI 2R01CA109545-05A1 Receptor Cross-Talk in Early Metastatic Dissemination STACK, MARY UNIVERSITY OF MISSOURI-COLUMBIA MO $296,819
Ovarian Cancer 2011 NCI 1R03CA159080-01 Mammographic Breast Density and Ovarian Cancer WERNLI, KAREN GROUP HEALTH COOPERATIVE WA $80,000
Ovarian Cancer 2011 NCI 5R43CA154339-02 Magnetic Nanoparticles and Quantum Dots for Diagnosis of Early Stage Ovarian Canc AGUILAR, ZORAIDA OCEAN NANOTECH, LLC AR $141,192
Ovarian Cancer 2011 NCI 5K25CA120350-05 A near-infrared contrast agent for targeted imaging of cancer ROMANOWSKI, MAREK UNIVERSITY OF ARIZONA AZ $145,343
Ovarian Cancer 2011 NCI 5R01CA085289-08 DNA Methylation and Ovarian Cancer NEPHEW, KENNETH INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $234,310
Ovarian Cancer 2011 NIGMS 5U01GM097119-02 NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN) MARDIS, ELAINE WASHINGTON UNIVERSITY MO $577,848
Ovarian Cancer 2011 NCI 1K08CA151892-01A1 Targeting Src Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer SIMPKINS, FIONA UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $161,408
Ovarian Cancer 2011 NCI 5R01CA125231-05 A Multi-State Study of Cancer Treatment and Outcomes Among American Indians RAMSEY, SCOTT FRED HUTCHINSON CANCER RESEARCH CENTER WA $284,400
Ovarian Cancer 2011 NCI 5R01CA132630-05 Chemical Probes for Metabolic Pathway Discovery in Human Disease CRAVATT, BENJAMIN SCRIPPS RESEARCH INSTITUTE CA $425,482
Ovarian Cancer 2011 NCI 5R01CA141154-02 Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data PEARCE, CELESTE UNIVERSITY OF SOUTHERN CALIFORNIA CA $631,470
Ovarian Cancer 2011 NINR 5F31NR012341-02 Prophylactic, risk-reducing surgery in BRCA-positive women: sexual functioning a TOLLIN, SHARON UNIVERSITY OF SOUTH FLORIDA FL $30,566
Ovarian Cancer 2011 NIBIB 5R01EB011523-02 Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu CHOI, HAK SOO BETH ISRAEL DEACONESS MEDICAL CENTER MA $489,293
Ovarian Cancer 2011 NCI 5R01CA127239-04 pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics NATARAJAN, AMARNATH UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $270,598
Ovarian Cancer 2011 NCI 5R01CA118678-05 Apoptotic regulators in ovarian cancer MOR, GIL YALE UNIVERSITY CT $305,017
Ovarian Cancer 2011 NCI 5K07CA131094-04 Epigentics and Female Reproductive Cancers PERRIN, MARY NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $139,320
Ovarian Cancer 2011 NCI 5R01CA092889-10 Role of TGFbeta in Microtubule Dynamics MULDER, KATHLEEN PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $259,680
Ovarian Cancer 2011 NCI 5K25CA128666-05 Comparative Proteomics Applied to the Avian Model of Ovarian Cancer HAWKRIDGE, ADAM NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $143,370
Ovarian Cancer 2011 NCI 5F32CA142117-03 Modulation of tumor-associated macrophage phenotype by S1P receptors BLAHO, VICTORIA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $54,734
Ovarian Cancer 2011 NCI 5R01CA094069-10 "Statistical Methods for Genetic Epidemiology" WHITTEMORE, ALICE STANFORD UNIVERSITY CA $558,584
Ovarian Cancer 2011 NCI 1R43CA159478-01 Utrasensitive bioassays using palladium catalyzed chemical amplification LELENTAL, MARK BIOFORMATIX, INC. CA $199,996
Ovarian Cancer 2011 NCI 1F32CA159523-01 Understanding the origin and pathogenesis of epithelial ovarian cancer KIM, JAEYEON BAYLOR COLLEGE OF MEDICINE TX $53,042
Ovarian Cancer 2011 NCI 5R01CA095319-09 Novel Fas/CD95 Signaling Mechanisms PETER, MARCUS NORTHWESTERN UNIVERSITY AT CHICAGO IL $264,833
Ovarian Cancer 2011 NCI 5R21CA143616-02 Ovarian cancer diagnosis by monitoring immune cell bound MUC16 (CA125) PATANKAR, MANISH UNIVERSITY OF WISCONSIN MADISON WI $156,650
Ovarian Cancer 2011 NCI 1F32CA159558-01 Role of p190RhoGEF (Rgnef) in cell motility and tumor progression MILLER, NICHOL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $53,042
Ovarian Cancer 2011 NCI 1R41CA156933-01A1 Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer KOPECEK, JINDRICH THERATARGET UT $148,304
Ovarian Cancer 2011 NCI 5R01CA134487-04 Mesothelin as biomarker and therapeutic target HELLSTROM, INGEGERD UNIVERSITY OF WASHINGTON WA $261,900
Ovarian Cancer 2011 NCI 1F31CA159804-01 Integrin Linked Kinase and Ovarian Cancer Metastasis BRUNEY, LANA UNIVERSITY OF MISSOURI-COLUMBIA MO $28,258
Ovarian Cancer 2011 NCI 5F31CA144083-03 Defining double-stranded RNA receptor induced apoptosis in ovarian cancer. SCHRAMM, DANIELLE VIRGINIA COMMONWEALTH UNIVERSITY VA $32,890
Ovarian Cancer 2011 NCI 5K05CA136967-03 Research and Mentoring on Energetic Factors and Cancer: Established Investigator BERNSTEIN, LESLIE CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $139,569
Ovarian Cancer 2011 NIAID 5SC1AI089073-03 Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer SON, DEOK-SOO MEHARRY MEDICAL COLLEGE TN $358,962
Ovarian Cancer 2011 NCI 5R01CA129142-03 Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women KINNEY, ANITA UNIVERSITY OF UTAH UT $571,413
Ovarian Cancer 2011 NCI 5U01CA152637-02 Breast and Ovary Cancer Clinical Validation Center LI, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $794,647
Ovarian Cancer 2011 NIAID 5K06AI004739-50 BIOCHEMISTRY OF VIRAL REPLICATION GREEN, MAURICE SAINT LOUIS UNIVERSITY MO $33,939
Ovarian Cancer 2011 NCI 5R01CA108990-07 Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer LOKSHIN, ANNA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $565,354
Ovarian Cancer 2011 NCI 1R03CA153815-01A1 The High Cost of Risk Reduction: Addressing Sexual Dysfunction after Oophorectomy BOBER, SHARON DANA-FARBER CANCER INSTITUTE MA $87,500
Ovarian Cancer 2011 NCI 5U01CA152755-02 An integrated systems biology approach for ovarian cancer biomarker discovery DIAMANDIS, ELEFTHERIOS MT SINAI HOSP-SAMUEL LUNENFELD RES INST CANADA $264,033
Ovarian Cancer 2011 NICHD 5R03HD058909-02 Regulation of Fetal Ovarian Development by GATA4 BOUMA, GERRIT COLORADO STATE UNIVERSITY-FORT COLLINS CO $70,560
Ovarian Cancer 2011 NCI 5U01CA084955-12 Atlantic Breast and Gynecologic Clinical Validation Center MARKS, JEFFREY DUKE UNIVERSITY NC $498,270
Ovarian Cancer 2011 NCI 5U01CA151648-02 RNA Nanotechnology in Cancer Therapy GUO, PEIXUAN UNIVERSITY OF CINCINNATI OH $435,815
Ovarian Cancer 2011 NCI 5R01CA085566-07 Psychological Intervention for Ovarian Cancer Patients MANNE, SHARON UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $519,524
Ovarian Cancer 2011 OD 5R03CA141318-02 Nuclear Pore Complex Architecture and Drug Resistance in Ovarian Carcinomas KOHTZ, DONALD MOUNT SINAI SCHOOL OF MEDICINE NY $82,208
Ovarian Cancer 2011 NCI 5R44CA125871-03 Camptothecin Analogs for Cancer Therapy MORGAN, LEE DEKK-TEC, INC. LA $392,344
Ovarian Cancer 2011 NCI 5R01CA122443-05 Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology GOODE, ELLEN MAYO CLINIC MN $474,657
Ovarian Cancer 2011 NICHD 5K12HD055881-05 VCU Building Interdisciplinary Research Careers in Women's Health STRAUSS, JEROME VIRGINIA COMMONWEALTH UNIVERSITY VA $50,000
Ovarian Cancer 2011 OD 5K12HD055881-05 VCU Building Interdisciplinary Research Careers in Women's Health STRAUSS, JEROME VIRGINIA COMMONWEALTH UNIVERSITY VA $446,801
Ovarian Cancer 2011 NCI 5F32CA144389-02 Transcription, Choice and the 3D Architecture of the Inactive X-Chromosome MUGFORD, JOSHUA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $51,326
Ovarian Cancer 2011 NCI 5K22CA138563-02 Obesity in ovarian cancer prognosis BANDERA, ELISA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $201,060
Ovarian Cancer 2011 NICHD 5K99HD059985-02 GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer WANG, CHENG UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $90,000
Ovarian Cancer 2011 NCI 5U01CA151461-02 Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer O'HALLORAN, THOMAS NORTHWESTERN UNIVERSITY AT CHICAGO IL $433,830
Ovarian Cancer 2011 NCI 5R44CA140047-03 Cancer Progeniyor Cell Markers CHEN, WEN-TIEN VITATEX, INC. NY $703,024
Ovarian Cancer 2011 NCI 5R43CA144591-02 EGFR-Targeted Nanoemulsions for Imaging and Therapy of Ovarian Cancer COLEMAN, TIMOTHY NEMUCORE MEDICAL INNOVATIONS, INC. MA $152,606
Ovarian Cancer 2011 NCI 5R01CA127562-05 Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer UENO, NAOTO UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $283,822
Ovarian Cancer 2011 NCI 5R01CA149260-02 Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy KUO, MACUS UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $318,015
Ovarian Cancer 2011 NCI 5R00CA133190-04 Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer COWDEN DAHL, KAREN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $241,530
Ovarian Cancer 2011 NCI 5R01CA151374-02 Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients MARTIN, LAINIE FOX CHASE CANCER CENTER PA $345,304
Ovarian Cancer 2011 NCI 5U01CA152990-02 Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery SKATES, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $720,550
Ovarian Cancer 2011 NIDDK 5R03DK090191-02 THE ROLE OF CALCIUM SIGNALING ON PTEN REGULATION CHOW, YIP UNIVERSITY OF CALIFORNIA SAN DIEGO CA $76,725
Ovarian Cancer 2011 NCI 1U24CA160036-01 Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers CHAN, DANIEL JOHNS HOPKINS UNIVERSITY MD $1,962,728
Ovarian Cancer 2011 NCI 1R01CA160541-01 Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer TAINSKY, MICHAEL WAYNE STATE UNIVERSITY MI $315,400
Ovarian Cancer 2011 NCI 1R33CA155618-01A1 Array Microscope Assay for Cancer Cell Mechanics SUPERFINE, RICHARD UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $322,411
Ovarian Cancer 2011 NCRR 1R21RR032333-01 Development of Nanoproteomic Technologies LEE, CHENG UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS MD $187,500
Ovarian Cancer 2011 NCI 1R01CA160998-01 Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry HASAN, TAYYABA MASSACHUSETTS GENERAL HOSPITAL MA $418,641
Ovarian Cancer 2011 NCI 1R21CA160917-01 Role of the Fractalkine Signaling in EOC BARBOLINA, MARIA UNIVERSITY OF ILLINOIS AT CHICAGO IL $202,968
Ovarian Cancer 2011 NCI 1R01CA154460-01A1 CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res SANTIN, ALESSANDRO YALE UNIVERSITY CT $343,413
Ovarian Cancer 2011 NCI 1R21CA161478-01 Regulation of lipogenesis by lysophosphatidic acid in ovarian cancer FANG, XIANJUN VIRGINIA COMMONWEALTH UNIVERSITY VA $162,581
Ovarian Cancer 2011 NCI 1R15CA161970-01 Development of aptamer-based detection and therapy strategies for ovarian cancer WHELAN, REBECCA OBERLIN COLLEGE OH $345,050
Ovarian Cancer 2011 NIGMS 2R01GM032136-29 Molecular Recognition of Proteins and Ligand Design JORGENSEN, WILLIAM YALE UNIVERSITY CT $353,873
Ovarian Cancer 2011 RMAP 1R21NS075702-01 Adaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening LENGYEL, ERNST UNIVERSITY OF CHICAGO IL $156,000
Ovarian Cancer 2011 NCI 2R01CA075334-14 MRI studies of angiogenesis in ovarian cancer NEEMAN, MICHAL WEIZMANN INSTITUTE OF SCIENCE ISRAEL $102,771
Ovarian Cancer 2011 NCI 2R01CA112240-06A1 The role of Fas as tumor promoter PETER, MARCUS NORTHWESTERN UNIVERSITY AT CHICAGO IL $294,148
Ovarian Cancer 2011 NCI 1R01CA151570-01A1 Co-registered photoacoustic and ultrasound imaging for non-invasive ovarian can ZHU, QUING UNIVERSITY OF CONNECTICUT STORRS CT $337,787
Ovarian Cancer 2011 NCCAM 1R01AT005295-01A2 Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer HALES, DALE SOUTHERN ILLINOIS UNIVERSITY CARBONDALE IL $363,750
Ovarian Cancer 2011 NCI 1R21CA156224-01A1 Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $348,000
Ovarian Cancer 2011 NCI 1R03CA162103-01 Bilateral oophorectomy and cancer risk and mortality in African American women BOGGS, DEBORAH BOSTON UNIVERSITY MEDICAL CAMPUS MA $61,516
Ovarian Cancer 2011 NCI 4R01CA131582-03 Identification of ovarian cancer plasma biomarkers SPEICHER, DAVID WISTAR INSTITUTE PA $413,376
Ovarian Cancer 2011 NCI 4R01CA135354-03 ARHI (DIRAS 3) in Autophagy and Dormancy of Ovarian Cancer BAST, ROBERT UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $306,953
Ovarian Cancer 2011 NCI 4R01CA060731-17 AFAP-110 as a cSrc activator in breast cancer FLYNN, DANIEL COMMONWEALTH MEDICAL COLLEGE PA $229,005
Ovarian Cancer 2011 NCI 1R01CA158318-01A1 mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $330,396
Ovarian Cancer 2011 NCI 3R01CA047135-22S1 Discovery of novel cytotoxic natural products from marine sponges and fungi CREWS, PHIL UNIVERSITY OF CALIFORNIA SANTA CRUZ CA $83,325
Ovarian Cancer 2011 NCI 1R03CA162511-01 Fish oil for the prevention and treatment of ovarian cancer HALES, DALE SOUTHERN ILLINOIS UNIVERSITY CARBONDALE IL $72,750
Ovarian Cancer 2011 NCI 1R13CA162868-01 Symposium on Hereditary Breast and Ovarian Cancers: Lessening the Burde MUGGIA, FRANCO NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $5,000
Ovarian Cancer 2011 NHGRI 1R21HG006415-01 Genetic Education to Promote Counseling Attendance after Surgical Treatment (GET VADAPARAMPIL, SUSAN H. LEE MOFFITT CANCER CTR & RES INST FL $250,500
Ovarian Cancer 2011 NCI 1R03CA157212-01A1 Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers BUCHANAN, ADAM DUKE UNIVERSITY NC $84,838
Ovarian Cancer 2011 NCI 5P30CA016042-36 5647 Women's Cancers GLASPY, JOHN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $54,704
Ovarian Cancer 2011 NCI 5P01CA070970-13 0006 Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma JONES, RICHARD JOHNS HOPKINS UNIVERSITY MD $311,009
Ovarian Cancer 2011 NCI 5P30CA077598-13 5757 Women's Cancer DOWNS, LEVI UNIVERSITY OF MINNESOTA TWIN CITIES MN $42,451
Ovarian Cancer 2011 NCI 3R01CA086984-12S1 Regulation of Ovarian Carcinoma Proteinases STACK, MARY UNIVERSITY OF MISSOURI-COLUMBIA MO $60,176
Ovarian Cancer 2011 NCI 7R01CA129927-04 Discovery of Gene Expression Signatures in Cancer Stroma WEST, ROBERT STANFORD UNIVERSITY CA $377,216
Ovarian Cancer 2011 RMAP 3DP2OD007391-01S1 ULTRASENSITIVE NANOLASERS FOR EPIGENETICS INVESTIGATIONS ARMANI, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $169,614
Ovarian Cancer 2011 NCI 4R44CA144586-02 IHC Test for BRCA1 Hereditary Ovarian Cancer HOLT, JEFFREY TISSUE GENETICS, INC. CO $399,246
Ovarian Cancer 2011 NCI 261200800001E-38-0-36 Repository Services for epidemiology studies HEIMBROOK, DAVID SAIC-FREDERICK, INC. MD $1,978,965
Ovarian Cancer 2011 NCI 3R01CA115483-07S1 Therapeutic Targeting Agents for Ovarian Cancer LAM, KIT UNIVERSITY OF CALIFORNIA DAVIS CA $58,992
Ovarian Cancer 2011 NCI 3R01CA115780-06S1 Diagnosis of Ovarian Cancer by Confocal Microendoscopy GMITRO, ARTHUR UNIVERSITY OF ARIZONA AZ $55,415
Ovarian Cancer 2011 NCI 5P01CA087969-12 7547 Ovarian Cancer TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $167,104
Ovarian Cancer 2011 NCI 5P01CA087969-12 7548 Statistical Methods ROSNER, BERNARD BRIGHAM AND WOMEN'S HOSPITAL MA $115,209
Ovarian Cancer 2011 NCI 5P01CA087969-12 7551 Biologic Specimen Management Core TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $474,112
Ovarian Cancer 2011 NCI 1F31CA165853-01 Therapeutic Targeting of Novel Antifolates to Solid Tumors via Folate Receptor MITCHELL, SHERMAINE WAYNE STATE UNIVERSITY MI $36,589
Ovarian Cancer 2011 NCI 5U19CA148112-02 8865 Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $523,791
Ovarian Cancer 2011 NCI 5U19CA148112-02 8866 Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1) SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $862,070
Ovarian Cancer 2011 NCI 5U19CA148112-02 8867 Functional assessment of genes and common genetic risk variants in ovarian cancer SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $599,443
Ovarian Cancer 2011 NCI 5U19CA148112-02 8868 Genetic and environmental interaction analyses and risk prediction modeling SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $493,574
Ovarian Cancer 2011 NCI 5P30CA014236-37 6412 Breast and Ovarian Oncology BERCHUCK, ANDREW DUKE UNIVERSITY NC $27,123
Ovarian Cancer 2011 NCI 5P50CA083638-13 7949 Gene Methylation Signatures for Predictive Classification of Response to Therapy CAIRNS, PAUL FOX CHASE CANCER CENTER PA $289,614
Ovarian Cancer 2011 NCI 5P50CA083638-13 7950 Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C DALY, MARY FOX CHASE CANCER CENTER PA $418,057
Ovarian Cancer 2011 NCI 5P50CA083638-13 7951 Therapeutic Micro RNA Strategies for Ovarian Cancer HAMILTON, THOMAS FOX CHASE CANCER CENTER PA $496,164
Ovarian Cancer 2011 NCI 5P50CA083638-13 7952 Targeting Signaling Networks Via Novel RNAi Approaches to Improve Therapy for O GODWIN, ANDREW FOX CHASE CANCER CENTER PA $323,787
Ovarian Cancer 2011 NCI 5P50CA083638-13 7955 Advancing T cell Therapy for Ovarian Cancer COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $516,260
Ovarian Cancer 2011 NCI 5P50CA083638-13 7956 Administrative Core SEIDEN, MICHAEL FOX CHASE CANCER CENTER PA $141,118
Ovarian Cancer 2011 NCI 5P50CA136393-03 7923 Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer KAUFMANN, SCOTT MAYO CLINIC MN $331,189
Ovarian Cancer 2011 NCI 5P50CA136393-03 7924 Mechanisms of Immune Suppression in Ovarian Cancer KNUTSON, KEITH MAYO CLINIC MN $264,989
Ovarian Cancer 2011 NCI 5P50CA136393-03 7925 Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer GALANIS, EVANTHIA MAYO CLINIC MN $344,948
Ovarian Cancer 2011 NCI 5P50CA136393-03 7926 Flavopiridol Reverses Platinum Resistance in Ovarian Cancer BIBLE, KEITH MAYO CLINIC MN $233,601
Ovarian Cancer 2011 NCI 5P50CA136393-03 7927 Administration Core HARTMANN, LYNN MAYO CLINIC MN $231,078
Ovarian Cancer 2011 NCI 5P50CA136393-03 7928 Biospecimens/Patient Registry Core BELL, DEBRA MAYO CLINIC MN $197,529
Ovarian Cancer 2011 NCI 5P50CA136393-03 7929 Biostatistics Core OBERG, ANN MAYO CLINIC MN $207,250
Ovarian Cancer 2011 NCI 5P50CA136393-03 7930 Animal Models KNUTSON, KEITH MAYO CLINIC MN $178,889
Ovarian Cancer 2011 NCI 5P50CA136393-03 7931 Developmental Research Program KAUFMANN, SCOTT MAYO CLINIC MN $130,351
Ovarian Cancer 2011 NCI 5P50CA136393-03 7932 Career Development Program COUCH, FERGUS MAYO CLINIC MN $65,176
Ovarian Cancer 2011 NCI 5U54CA151662-02 8769 Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer GERNGROSS, TILLMAN DARTMOUTH COLLEGE NH $1,056,029
Ovarian Cancer 2011 NCI 5U54CA151662-02 8772 Magnetic nanoparticle Immunotherapy against Ovarian Cancer CONEJO-GARCIA, JOSE DARTMOUTH COLLEGE NH $236,995
Ovarian Cancer 2011 NCI 5U54CA151662-02 8775 Toxicology, Pathology and Biodistribution Core (TPB Core) LEWIS, LIONEL DARTMOUTH COLLEGE NH $92,723
Ovarian Cancer 2011 NCI 261200900010C-3-0-1 BIOMEDICAL (MANAGEMENT/SUPPORT) MADHAVEN, SUBHA GEORGETOWN UNIVERSITY DC $1,200,000
Ovarian Cancer 2011 NIGMS 3R01GM088055-12S1 Structural and Functional Characterization of BRCA1/BARD1 KLEVIT, RACHEL UNIVERSITY OF WASHINGTON WA $115,500
Ovarian Cancer 2011 NIAID 5P01AI068730-05 0005 COMPLEMENT IN CANCER ESTABLISHMENT AND GROWTH COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $284,730
Ovarian Cancer 2011 NCI 5U54CA151884-02 5023 Nanoformulations for siRNA Delivery to Ovarian Cancer SHARP, PHILLIP MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $260,940
Ovarian Cancer 2011 NCI 5P50CA083636-13 7964 Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women URBAN, NICOLE FRED HUTCHINSON CANCER RESEARCH CENTER WA $114,878
Ovarian Cancer 2011 NCI 5P50CA083636-13 7965 Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V DRESCHER, CHARLES FRED HUTCHINSON CANCER RESEARCH CENTER WA $257,611
Ovarian Cancer 2011 NCI 5P50CA083636-13 7966 MicroRNA Signature of Poorly Resectable Ovarian Cancer TEWARI, MUNEESH FRED HUTCHINSON CANCER RESEARCH CENTER WA $200,810
Ovarian Cancer 2011 NCI 5P50CA083636-13 7967 Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient TANIGUCHI, TOSHIYASU FRED HUTCHINSON CANCER RESEARCH CENTER WA $257,007
Ovarian Cancer 2011 NCI 5P50CA083636-13 7968 Vaccinating against IGFBP-2 to prevent ovarian cancer relapse DISIS, MARY UNIVERSITY OF WASHINGTON WA $437,712
Ovarian Cancer 2011 NCI 5P50CA083636-13 7969 Leadership and Administration Core URBAN, NICOLE FRED HUTCHINSON CANCER RESEARCH CENTER WA $139,711
Ovarian Cancer 2011 NCI 5P50CA083636-13 7970 Clinical Specimen Management and Characterization Core KNUDSEN, BEATRICE FRED HUTCHINSON CANCER RESEARCH CENTER WA $263,687
Ovarian Cancer 2011 NCI 5P50CA083636-13 7971 Participant Recruitment, Enrollment and Characterization Core DRESCHER, CHARLES FRED HUTCHINSON CANCER RESEARCH CENTER WA $230,576
Ovarian Cancer 2011 NCI 5P50CA083636-13 7972 Biostatistics and Informatics Core MCINTOSH, MARTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $158,052
Ovarian Cancer 2011 NCI 5P50CA083636-13 7973 Developmental Research Program MCINTOSH, MARTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $62,478
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer